NIH is offering a grant to enhance understanding of infection-related cancers, focusing on the roles of co-infection in cancer and investigating co-infections with known oncogenic agents. The grant aims to provide opportunities for novel prevention and treatment strategies. Coinfection involves concurrent or sequential infections by two or more infectious agents, including viruses, bacteria, parasites, and other microorganisms. Closing date for applications is Jan 07, 2023, 12:00:00 AM EST.
Opportunity ID: 322672
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-20-061 |
| Funding Opportunity Title: | Co-infection and Cancer (R21 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 22, 2019 |
| Last Updated Date: | Nov 22, 2019 |
| Original Closing Date for Applications: | Jan 07, 2023 |
| Current Closing Date for Applications: | Jan 07, 2023 |
| Archive Date: | Feb 12, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Independent school districts City or township governments Public housing authorities/Indian housing authorities Others (see text field entitled “Additional Information on Eligibility” for clarification) For profit organizations other than small businesses Private institutions of higher education State governments County governments Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This initiative seeks to enhance our mechanistic and epidemiologic understanding of infection-related cancers, with a focus on the etiologic roles of co-infection in cancer. Preference will be given to investigations of co-infections with known oncogenic agents (e.g., Helicobacter pylori [H. pylori] and Epstein Barr virus [EBV]; excluding human immunodeficiency virus [HIV]) and of co-infections that engendered novel opportunities for prevention and treatment. Coinfection is defined as the occurrence of infections by two or more infectious (pathogenic or nonpathogenic) agents either concurrently or sequentially and includes both acute and chronic infections by viruses, bacteria, parasites, and/or other microorganisms. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-20-061.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 322672 Full Announcement-PAR-20-061 -> PAR-20-061-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00256777 | Feb 17, 2020 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00259762 | Feb 17, 2020 | Jan 24, 2022 | View | |
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00270290 | Nov 16, 2021 | Jan 24, 2023 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00278098 | Nov 08, 2022 | Jan 07, 2023 | View |
Package 1
Mandatory forms
322672 RR_SF424_2_0-2.0.pdf
322672 PHS398_CoverPageSupplement_4_0-4.0.pdf
322672 RR_OtherProjectInfo_1_4-1.4.pdf
322672 PerformanceSite_2_0-2.0.pdf
322672 RR_KeyPersonExpanded_2_0-2.0.pdf
322672 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
322672 RR_Budget_1_4-1.4.pdf
322672 RR_SubawardBudget30_1_4-1.4.pdf
322672 PHS398_ModularBudget_1_2-1.2.pdf
322672 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
322672 RR_SF424_2_0-2.0.pdf
322672 PHS398_CoverPageSupplement_5_0-5.0.pdf
322672 RR_OtherProjectInfo_1_4-1.4.pdf
322672 PerformanceSite_2_0-2.0.pdf
322672 RR_KeyPersonExpanded_2_0-2.0.pdf
322672 PHS398_ResearchPlan_4_0-4.0.pdf
322672 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
322672 RR_Budget_1_4-1.4.pdf
322672 RR_SubawardBudget30_1_4-1.4.pdf
322672 PHS398_ModularBudget_1_2-1.2.pdf
322672 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
322672 RR_SF424_5_0-5.0.pdf
322672 PHS398_CoverPageSupplement_5_0-5.0.pdf
322672 RR_OtherProjectInfo_1_4-1.4.pdf
322672 PerformanceSite_4_0-4.0.pdf
322672 RR_KeyPersonExpanded_4_0-4.0.pdf
322672 PHS398_ResearchPlan_4_0-4.0.pdf
322672 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
322672 RR_Budget_3_0-3.0.pdf
322672 RR_SubawardBudget30_3_0-3.0.pdf
322672 PHS398_ModularBudget_1_2-1.2.pdf
322672 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 4
Mandatory forms
322672 RR_SF424_5_0-5.0.pdf
322672 PHS398_CoverPageSupplement_5_0-5.0.pdf
322672 RR_OtherProjectInfo_1_4-1.4.pdf
322672 PerformanceSite_4_0-4.0.pdf
322672 RR_KeyPersonExpanded_4_0-4.0.pdf
322672 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
322672 RR_Budget_3_0-3.0.pdf
322672 RR_SubawardBudget30_3_0-3.0.pdf
322672 PHS398_ModularBudget_1_2-1.2.pdf
322672 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
